Evidence map›Paper›PMID 38239683›Full record

ArticleChemical science2024

Covalent-organic framework nanobionics for robust cytoprotection.

Jieying Liang, Qianfan Chen, Joel Yong, Hiroki Suyama, Joanna Biazik, Bosiljka Njegic, Aditya Rawal, Kang Liang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jieying LiangSchool of Chemical Engineering and Australian Centre for NanoMedicine, The University of New South Wales Sydney NSW 2052 Australia jieying.liang@unsw.edu.au kang.liang@unsw.edu.au.
Qianfan ChenGraduate School of Biomedical Engineering, The University of New South Wales Sydney NSW 2052 Australia.
Joel YongSchool of Chemical Engineering and Australian Centre for NanoMedicine, The University of New South Wales Sydney NSW 2052 Australia jieying.liang@unsw.edu.au kang.liang@unsw.edu.au.
Hiroki SuyamaUNSW RNA Institute, The University of New South Wales Sydney NSW 2052 Australia.
Joanna BiazikElectron Microscope Unit, Mark Wainwright Analytical Centre, The University of New South Wales Sydney NSW 2052 Australia.
Bosiljka NjegicNuclear Magnetic Resonance Facility, Mark Wainwright Analytical Centre, University of New South Wales Sydney NSW 2052 Australia.
Aditya RawalNuclear Magnetic Resonance Facility, Mark Wainwright Analytical Centre, University of New South Wales Sydney NSW 2052 Australia.ORCID https://orcid.org/0000-0002-5396-1265
Kang LiangSchool of Chemical Engineering and Australian Centre for NanoMedicine, The University of New South Wales Sydney NSW 2052 Australia jieying.liang@unsw.edu.au kang.liang@unsw.edu.au.ORCID https://orcid.org/0000-0003-3985-7688

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a novel study introducing a durable and robust covalent-organic framework (COF) nanocoating, developed

Identifiers

PMID38239683
PMCPMC10793206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.